Stay updated with breaking news from Ip Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, today announced that it has closed a £26 million ($33.1 million USD) Series B follow-on financing round, led by Panakes Partners.
London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.
Investegate announcements from Transaction in Own Shares
Investegate announcements from Total Voting Rights
Cambridge Cognition Holdings plc has announced the appointment of Stuart Gall and Philip Rodgers as independent non-executive Directors, to support the company's growth plans in the healthcare and technology sectors.